322 related articles for article (PubMed ID: 28040187)
1. Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
Kurtul A; Yarlioglues M; Duran M
Am J Cardiol; 2017 Mar; 119(6):819-825. PubMed ID: 28040187
[TBL] [Abstract][Full Text] [Related]
2. CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome.
Chaudhary AK; Pathak V; Kunal S; Shukla S; Pathak P
Indian Heart J; 2019; 71(4):303-308. PubMed ID: 31779857
[TBL] [Abstract][Full Text] [Related]
3. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the CHA
Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of systemic immune-inflammatory index combined with CHA2DS2-VASC score for contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Zhu Y; Qiu H; Wang Z; Shen G; Li W
Int Urol Nephrol; 2023 Nov; 55(11):2897-2903. PubMed ID: 37000380
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of combining the level of fibrinogen and CHA2DS2-VASC Score for contrast-induced acute kidney injury in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Li J; Wang Z; Zhang B; Zheng D; Lu Y; Li W
Int Urol Nephrol; 2022 Sep; 54(9):2385-2392. PubMed ID: 35182313
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aksoy F; Bagcı A
Rev Assoc Med Bras (1992); 2019 Nov; 65(11):1384-1390. PubMed ID: 31800901
[TBL] [Abstract][Full Text] [Related]
8. CHA2DS2-VASC Score Predicts Risk of Contrast-Induced Nephropathy in Non-ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions.
Baydar O; Kilic A
Kidney Dis (Basel); 2019 Oct; 5(4):266-271. PubMed ID: 31768384
[TBL] [Abstract][Full Text] [Related]
9. Validation of the CHA2DS2-VASc Score in Predicting Coronary Atherosclerotic Burden and In-Hospital Mortality in Patients With Acute Coronary Syndrome.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Jul; 120(1):8-14. PubMed ID: 28479165
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Value of CHA
Borovac JA; Kwok CS; Mohamed MO; Fischman DL; Savage M; Alraies C; Kalra A; Nolan J; Zaman A; Ahmed J; Bagur R; Mamas MA
Cardiovasc Revasc Med; 2021 Aug; 29():61-68. PubMed ID: 32828675
[TBL] [Abstract][Full Text] [Related]
11. CHA2DS2-VASc score predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction, who have undergone primary percutaneous coronary intervention.
Cicek G; Yıldırım E
Kardiol Pol; 2018; 76(1):91-98. PubMed ID: 28980300
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y
Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726
[TBL] [Abstract][Full Text] [Related]
13. Relationship between thiol, disulphide volume and contrast-induced nephropathy in acute coronary syndrome patients treated with percutaneous coronary intervention.
Elcik D; Kelesoglu S; Yilmaz Y; Cetinkaya Z; Sulaiman J; Yurt R; Neselioglu S; Erel O; Inanc MT; Oguzhan A
Scand J Clin Lab Invest; 2021 May; 81(3):173-180. PubMed ID: 33528282
[TBL] [Abstract][Full Text] [Related]
14. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
[TBL] [Abstract][Full Text] [Related]
15. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
Kocas C; Yildiz A; Abaci O; Karaca OS; Firdin N; Dalgic Y; Bostan C; Ersanli M
Angiology; 2015 Nov; 66(10):964-8. PubMed ID: 25852211
[TBL] [Abstract][Full Text] [Related]
16. CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.
Ipek G; Onuk T; Karatas MB; Gungor B; Osken A; Keskin M; Oz A; Tanik O; Hayiroglu MI; Yaka HY; Ozturk R; Bolca O
Angiology; 2016 Oct; 67(9):840-5. PubMed ID: 26685178
[TBL] [Abstract][Full Text] [Related]
17. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions.
Chou RH; Huang PH; Hsu CY; Leu HB; Huang SS; Huang CC; Chen JW; Lin SJ
J Formos Med Assoc; 2016 Jul; 115(7):501-9. PubMed ID: 26830105
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.
Xu ZR; Chen J; Liu YH; Liu Y; Tan N
BMC Cardiovasc Disord; 2019 Feb; 19(1):36. PubMed ID: 30744553
[TBL] [Abstract][Full Text] [Related]
19. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
